Amarantus BioScience Holdings (AMBS) Starts Presentation at LD Micro Conference

Amarantus BioScience Holdings is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The company has licensed Eltoprazine, a phase 2b ready small molecule indicated for Parkinson’s disease Levodopa induced dyskinesia and adult ADHD. AMBS has an exclusive worldwide license to the Lymphocyte Proliferation test for Alzheimer’s disease. For more information, visit the company’s website at www.amarantus.com